These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 31865012

  • 21. Design, synthesis and bioevaluation of 2,7-diaryl-pyrazolo[1,5-a]pyrimidines as tubulin polymerization inhibitors.
    Liu R, Zhang S, Huang M, Guo Z, Li L, Li M, Wu L, Guan Q, Zhang W.
    Bioorg Chem; 2021 Oct; 115():105220. PubMed ID: 34352709
    [Abstract] [Full Text] [Related]

  • 22. Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors.
    Fu DJ, Liu SM, Li FH, Yang JJ, Li J.
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1050-1059. PubMed ID: 32299262
    [Abstract] [Full Text] [Related]

  • 23. Ligand- and structural-based discovery of potential small molecules that target the colchicine site of tubulin for cancer treatment.
    Guo Q, Zhang H, Deng Y, Zhai S, Jiang Z, Zhu D, Wang L.
    Eur J Med Chem; 2020 Jun 15; 196():112328. PubMed ID: 32320841
    [Abstract] [Full Text] [Related]

  • 24. Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway.
    Song J, Wang SH, Song CH, Zhang WX, Zhu JX, Tian XY, Fu XJ, Xu Y, Jin CY, Zhang SY.
    Eur J Med Chem; 2022 Oct 05; 240():114583. PubMed ID: 35834904
    [Abstract] [Full Text] [Related]

  • 25. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.
    Majcher U, Urbaniak A, Maj E, Moshari M, Delgado M, Wietrzyk J, Bartl F, Chambers TC, Tuszynski JA, Huczyński A.
    Bioorg Chem; 2018 Dec 05; 81():553-566. PubMed ID: 30248507
    [Abstract] [Full Text] [Related]

  • 26. Design and bio-evaluation of novel millepachine derivatives targeting tubulin colchicine binding site for treatment of osteosarcoma.
    Geng D, Chen Z, Li Y, Liu T, Wang L.
    Bioorg Chem; 2024 Oct 05; 151():107624. PubMed ID: 39002514
    [Abstract] [Full Text] [Related]

  • 27. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation.
    Hagras M, El Deeb MA, Elzahabi HSA, Elkaeed EB, Mehany ABM, Eissa IH.
    J Enzyme Inhib Med Chem; 2021 Dec 05; 36(1):640-658. PubMed ID: 33588683
    [Abstract] [Full Text] [Related]

  • 28. Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.
    Wang SY, Liu X, Meng LW, Li MM, Li YR, Yu GX, Song J, Zhang HY, Chen P, Zhang SY, Hu T.
    Bioorg Med Chem Lett; 2021 Jul 01; 43():128095. PubMed ID: 33965530
    [Abstract] [Full Text] [Related]

  • 29. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
    Cao D, Liu Y, Yan W, Wang C, Bai P, Wang T, Tang M, Wang X, Yang Z, Ma B, Ma L, Lei L, Wang F, Xu B, Zhou Y, Yang T, Chen L.
    J Med Chem; 2016 Jun 23; 59(12):5721-39. PubMed ID: 27213819
    [Abstract] [Full Text] [Related]

  • 30. New indolesulfonamide derivatives targeting the colchicine site of tubulin: synthesis, anti-tumour activity, structure-activity relationships, and molecular modelling.
    Vicente-Blázquez A, González M, Medarde M, Mollinedo F, Peláez R.
    J Enzyme Inhib Med Chem; 2021 Dec 23; 36(1):2025-2044. PubMed ID: 34514909
    [Abstract] [Full Text] [Related]

  • 31. The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site.
    Boichuk S, Galembikova A, Syuzov K, Dunaev P, Bikinieva F, Aukhadieva A, Zykova S, Igidov N, Gankova K, Novikova M, Kopnin P.
    Molecules; 2021 Sep 24; 26(19):. PubMed ID: 34641324
    [Abstract] [Full Text] [Related]

  • 32. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.
    Wang G, Liu W, Gong Z, Huang Y, Li Y, Peng Z.
    J Enzyme Inhib Med Chem; 2020 Dec 24; 35(1):139-144. PubMed ID: 31724435
    [Abstract] [Full Text] [Related]

  • 33. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.
    Rahimzadeh Oskuei S, Mirzaei S, Reza Jafari-Nik M, Hadizadeh F, Eisvand F, Mosaffa F, Ghodsi R.
    Bioorg Chem; 2021 Jul 24; 112():104904. PubMed ID: 33933802
    [Abstract] [Full Text] [Related]

  • 34. Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities.
    Ren Y, Ruan Y, Cheng B, Li L, Liu J, Fang Y, Chen J.
    Bioorg Med Chem; 2021 Sep 15; 46():116376. PubMed ID: 34455231
    [Abstract] [Full Text] [Related]

  • 35. The cytotoxic natural compound erianin binds to colchicine site of β-tubulin and overcomes taxane resistance.
    Yan W, Zhou Y, Yuan X, Bai P, Tang M, Chen L, Wei H, Yang J.
    Bioorg Chem; 2024 Sep 15; 150():107569. PubMed ID: 38905886
    [Abstract] [Full Text] [Related]

  • 36. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
    Yao Y, Huang T, Wang Y, Wang L, Feng S, Cheng W, Yang L, Duan Y.
    J Enzyme Inhib Med Chem; 2022 Dec 15; 37(1):652-665. PubMed ID: 35109719
    [Abstract] [Full Text] [Related]

  • 37. Design, synthesis, and biological evaluation of biotinylated colchicine derivatives as potential antitumor agents.
    Wang C, Zhang Y, Wang Z, Li Y, Guan Q, Xing D, Zhang W.
    J Enzyme Inhib Med Chem; 2022 Dec 15; 37(1):411-420. PubMed ID: 34915785
    [Abstract] [Full Text] [Related]

  • 38. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors.
    Yang F, He CP, Diao PC, Hong KH, Rao JJ, Zhao PL.
    Bioorg Med Chem Lett; 2019 Jan 01; 29(1):22-27. PubMed ID: 30448234
    [Abstract] [Full Text] [Related]

  • 39. Design, synthesis and bio-evaluation of novel 2-aryl-4-(3,4,5-trimethoxy-benzoyl)-5-substituted-1,2,3-triazoles as the tubulin polymerization inhibitors.
    Huang L, Liu M, Man S, Ma D, Feng D, Sun Z, Guan Q, Zuo D, Wu Y, Zhang W, Bao K.
    Eur J Med Chem; 2020 Jan 15; 186():111846. PubMed ID: 31740055
    [Abstract] [Full Text] [Related]

  • 40. Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.
    Sun M, Yuan M, Kang Y, Qin J, Zhang Y, Duan Y, Wang L, Yao Y.
    J Enzyme Inhib Med Chem; 2022 Dec 15; 37(1):339-354. PubMed ID: 34979843
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.